This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum
See You Next Year! 26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Brian Cafferty, PhD
Director at Beam Therapeutics


Brian Cafferty is Director of RNA Chemistry and Process Development at Beam Therapeutics. His lab develops technologies and processes to enhance the quality of oligonucleotides used in gene editing. Prior to Beam, Brian worked at Casebia Therapeutics where he developed approaches to produce long RNA oligos, and Harvard University where he worked on molecular information storage and biologically inspired reaction networks. He received a Ph.D. in Chemistry from Georgia Tech, where he investigated the structure of noncanonical nucleic acids and models for the origin of RNA.

Agenda Sessions

  • From Circles to Conjugates: Rethinking the Architecture of guide RNA